Work

API generation program: Active immunotherapy CAD106 slows amyloid deposition in cognitively unimpaired APOE4 homozygotes

Year: 2021

Type: article

Study design: Clinical Trial

Source: Alzheimer s & Dementia

DOI: 10.1002/alz.051287

Authors: Marie‐Emmanuelle Riviere, Raymond Scott Turner, Yihan Sui, Nathalie Laurent, Jessica B. Langbaum, Pilar Cazorla, Javier Ricart, Nicholas Seneca, Angelika Caputo, Eric M. Reiman, Pierre N. Tariot, Ana Graf

Institutions: Novartis (Switzerland), Georgetown University Medical Center, Novartis (United States), Banner Alzheimer’s Institute, Novartis (Spain), Novartis Institutes for BioMedical Research

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4205104569

FWCI: 0.157

Cites:

Cited by: 2

Related to: 10